Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of Cornulin as target in preparation of drug for preventing and treating psoriasis

A technology for psoriasis and drugs, applied in the field of preparation and prevention of psoriasis, can solve the problems of patient satisfaction, unclear etiology, and easy recurrence of the disease, and achieve good safety and good safety effects

Active Publication Date: 2017-05-10
XI AN JIAOTONG UNIV
View PDF2 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There are many treatments for psoriasis, including corticosteroids, retinoic acids, vitamin D3 derivatives, calcineurin inhibitors and other drugs, but because the etiology of the disease is unclear, The curative effect of many current treatment methods does not satisfy the patients, and the disease is prone to relapse. Due to the adverse drug reactions or drug prices in the treatment of psoriasis, the clinical use of these drugs is limited.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Cornulin as target in preparation of drug for preventing and treating psoriasis
  • Application of Cornulin as target in preparation of drug for preventing and treating psoriasis
  • Application of Cornulin as target in preparation of drug for preventing and treating psoriasis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] The present invention will be further described in detail below in conjunction with specific embodiments, which are explanations of the present invention rather than limitations.

[0028] The present invention finds that the expression of cornulin increases in psoriasis patient skin lesions and imiquimod mouse skin lesions, and application of M5 (IL-17A, IL-22, IL-1a, OSM and TNF-a mixture) stimulates HaCaT and After HEKa cells simulate the psoriasis cell level, the expression of cornulin increases; these suggest that cornulin is positively correlated with the development of psoriasis, and the present invention will be further described in detail below.

[0029] 1) Establishment of imiquimod mouse model

[0030] Purchase 6-7 week BALB / c mice, after 2% chloral hydrate anesthesia, shave the back hair about 2*2cm in size, apply imiquimod cream 62.5mg, once a day, apply different concentrations (0.5ng / ml , 1ng / ml and 2ng / ml) of CRNN antibody (catalog number: 11799-1-AP) 40...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of Cornulin as a target in preparation of a drug for preventing and treating psoriasis. Cornulin is taken as the drug target on the gene level and / or the protein level for the drug. Cornulin is positively correlated with development of psoriasis, when a Cornulin antibody with proper concentration is used for treating an imiquimod mouse model of psoriasis, scales and skin lesion thickness can be improved, and AKT signals can be inhibited to inhibit development of psoriasis and inhibit skin lesion for returning to normal; compared with other psoriasis treating drugs, and the Cornulin antibody has the advantages that the intervention target is clearer, that is, AKT signal related molecular pathways in inflammatory pathways for psoriasis incidence are targeted.

Description

technical field [0001] The invention belongs to the technical field of biomedicine and relates to the application of Cornulin in the preparation and prevention of psoriasis. Background technique [0002] Psoriasis is an inflammatory, immune-mediated chronic skin disease characterized by hyperplasia and abnormal differentiation of keratinocytes and infiltration of inflammatory cells. The clinical feature of psoriasis is silvery-white scales overlying erythema, and the long-term disease development seriously affects the quality of life of patients. The histopathology of typical psoriasis is: epidermal hypokeratosis, often accompanied by hyperkeratosis; granular layer disappears, spinous layer is hypertrophic, epidermal process is extended, and the lower end is widened, which can coincide with the adjacent epidermal process, and dermal papilla is extended, The spinous layer above it becomes thinner. Basal cells may have mild sponging, or even vacuolation or edema degeneration...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/395A61K31/7105A61K48/00A61P17/06C12Q1/68G01N33/68G01N33/558
CPCA61K39/395G01N33/558G01N33/6881A61K31/7105C12Q1/686C12Q1/6883A61K2039/505G01N2800/20G01N2333/4704G01N2333/46C12Q2531/113C12Q2545/114C12Q2561/113C12Q2563/107
Inventor 郑焱李昌吉杨佩雯
Owner XI AN JIAOTONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com